Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel rhodium-catalyzed one-step synthesis offers high selectivity and supply chain stability for pharmaceutical intermediates manufacturing ensuring reliable sourcing for global drug development pipelines.
Discover a novel industrial route for Apalutamide intermediates using copper catalysis. This patent-backed method ensures high purity, safety, and cost-effective manufacturing.
Patent CN118307453A details a nickel-catalyzed route for alkylaryl sulfoxides, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN112479876A reveals a novel chiral resolution route for oxazepine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel synthesis method for complex fused-ring intermediates. Cost-effective, scalable, high purity. Reliable supply for global pharmaceutical manufacturing partners.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Patent CN103724340A discloses a novel synthesis of thiazole derivatives featuring benzo-oxygen heterocycles, offering improved lipophilicity and streamlined manufacturing for pharmaceutical intermediates.
Novel asymmetric catalytic synthesis of chiral nitrogen-bridged rings. High stereoselectivity, scalable process for pharmaceutical intermediates and supply chain reliability.
Novel copper-catalyzed asymmetric propargyl substitution method ensures high ee and scalable production for pharmaceutical intermediates.
Patent CN103524469A discloses a high-yield synthesis for C-glucoside SGLT2 inhibitors, offering improved purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN109810125A reveals aqueous Henry reaction breakthrough enabling cost reduction in pharmaceutical intermediates manufacturing with high-purity pharmaceutical intermediates.
Patent CN102307845B details a novel cinacalcet hydrochloride synthesis route offering improved purity and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel chiral intermediate synthesis for Moxifloxacin. High purity, scalable process, cost-effective manufacturing solution for global supply chains.
Efficient synthesis of benzodioxane-thiazole hybrids offering improved lipophilicity and scalable routes for drug discovery applications.
Novel synthesis route for Tamiflu intermediate avoiding toxic selenium. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111732600A reveals a stable cuprous complex enabling mild, one-pot benzimidazole synthesis. Discover cost-effective manufacturing solutions.
Patent CN101898998B reveals a safer, high-yield route for Tirofiban intermediates. Discover cost reduction in API manufacturing and scalable production methods.
Patent CN105017150A details a palladium-catalyzed asymmetric hydrogenation method for high-purity chiral exocyclic amines, offering significant supply chain and cost advantages.
Discover the advanced chemical synthesis of epidaunorubicin intermediates via patent CN109293613B. Offers superior purity and supply stability over fermentation methods.
Patent CN115385920A details a scalable BTK inhibitor refining method achieving 99.4% purity without column chromatography, offering significant cost reduction in API manufacturing.